A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis
- James Foran
- , Farhad Ravandi
- , William Wierda
- , Guillermo Garcia-Manero
- , Srdan Verstovsek
- , Tapan Kadia
- , Jan Burger
- , Murray Yule
- , Gillian Langford
- , John Lyons
- , John Ayrton
- , Victoria Lock
- , Gautham Borthakur
- , Jorge Cortes
- , Hagop Kantarjian
Research output: Contribution to journal › Article › peer-review
26
Link opens in a new tab
Scopus
citations